U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
2283122831Sensor Off Study Using a Nellcor USB Pulse Oximetry Monitor Interface CableCompletedNo Results AvailableHealthy Volunteershttps://ClinicalTrials.gov/show/NCT02265783
2283222832An International Clinical Program for the Diagnosis and Treatment of Children With EpendymomaRecruitingNo Results AvailableChildhood EpendymomaDrug: 16 weeks of VEC + CDDP|Drug: VEC + HD-MTX|Drug: Chemotherapy + Valproate|Radiation: Conformal radiotherapy|Drug: VEC|Drug: Chemotherapy|Radiation: conformal radiotherapy +/- boosthttps://ClinicalTrials.gov/show/NCT02265770
2283322833Behavioral Interventions to Prevent or Delay DementiaRecruitingNo Results AvailableMild Cognitive Impairment|Memory Disorders|Mild Dementia|Impaired Cognition|Mild Cognitive Disorder|Amnestic Disorder|Dementia and Amnestic Conditions|Poor Short-term Memory|Memory ImpairmentBehavioral: Cognitive Rehabilitation|Behavioral: Computer Brain Fitness Training|Behavioral: Support Group (patient and partner)|Behavioral: Wellness Education|Behavioral: Physical Exercisehttps://ClinicalTrials.gov/show/NCT02265757
2283422834Safety and Efficacy Study of a Biologic to Treat Systemic Lupus ErythematosusRecruitingNo Results AvailableLupusDrug: BMS-931699|Drug: Placebo matching BMS-931699https://ClinicalTrials.gov/show/NCT02265744
2283522835Study Evaluating Venetoclax in Subjects With Relapsed or Refractory Non-hodgkin Lymphoma or Multiple MyelomaRecruitingNo Results AvailableNon-Hodgkin Lymphoma|Multiple MyelomaDrug: venetoclaxhttps://ClinicalTrials.gov/show/NCT02265731
2283622836A Study To Evaluate The Difference In iPad-Based Cognitive Video Game (Akili Interactive's Project: EVO) Performance In Amyloid-Positive Versus Amyloid-Negative Healthy Elderly VolunteersRecruitingNo Results AvailableHealthyDrug: Ritalin|Drug: Placebo|Drug: Ritalin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02265718
2283722837A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (RA)RecruitingNo Results AvailableRheumatoid ArthritisDrug: Baricitinib|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02265705
2283822838Safety, Tolerability and Pharmacokinetics of Increasing Doses of BIIL 284 BS in Adult and Pediatric Cystic Fibrosis (CF) PatientsCompletedNo Results AvailableCystic FibrosisDrug: BIIL 284 BS, low dose, pediatric patients|Drug: BIIL 284 BS, medium dose, pediatric patients|Drug: BIIL 284 BS, high dose, pediatric patients|Drug: BIIL 284 BS, low dose, adult patients|Drug: BIIL 284 BS, medium dose, adult patients|Drug: BIIL 284 BS, high dose, adult patients|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02265679
2283922839Relative Bioavailability, Safety and Tolerability of Two Tablet Formulations of BIIL 284 BSCompletedNo Results AvailableHealthyDrug: BIIL 284 BS Tablet FF|Drug: BIIL 284 BS tablet C|Other: standard breakfasthttps://ClinicalTrials.gov/show/NCT02265666
2284022840Relative Bioavailability, Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Healthy VolunteersCompletedNo Results AvailableHealthyDrug: BIIL 284 BS tablet C|Drug: BIIL 284 BS tablet D|Drug: BIIL 284 BS WIF tablethttps://ClinicalTrials.gov/show/NCT02265653
2284122841Relative Bioavailability, Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Healthy VolunteersCompletedNo Results AvailableHealthyDrug: BIIL 284 BS boli|Drug: BIIL 284 BS tablet C|Other: standard breakfasthttps://ClinicalTrials.gov/show/NCT02265640
2284222842Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Patients With Hepatic Impairment in Comparison to Healthy VolunteersCompletedNo Results AvailableHepatic InsufficiencyDrug: BIIL 284 BShttps://ClinicalTrials.gov/show/NCT02265627
2284322843PGS Using Microarray in IVF Patients With Repeated Implantation FailureRecruitingNo Results AvailableInfertilityGenetic: PGShttps://ClinicalTrials.gov/show/NCT02265614
2284422844End-of-Life Health Care Decisions by Patients With Advanced CancerActive, not recruitingNo Results AvailableNeoplasmsOther: computer-based decision aid|Other: standard carehttps://ClinicalTrials.gov/show/NCT02265601
2284522845Healthy Approach to Physical and Psychological Problems in Youngsters With IBD (HAPPY-IBD).RecruitingNo Results AvailableInflammatory Bowel Disease (IBD)|Ulcerative Colitis|Crohn's Disease|Anxiety|DepressionBehavioral: Cognitive behavioral therapyhttps://ClinicalTrials.gov/show/NCT02265588
2284622846Hylenex-Assisted Resuscitation in Kenya (HARK) Trial for the Management of DehydrationEnrolling by invitationNo Results AvailableDehydrationDrug: Hyaluronic Acidhttps://ClinicalTrials.gov/show/NCT02265575
2284722847Rectal Misoprostol and Blood Loss During Abdominal HysterectomyRecruitingNo Results AvailableBlood LossDrug: Misoprostol|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02265562
2284822848Radiomics for Prediction of Long Term Survival and Local Failure After Stereotactic Radiotherapy for Brain MetastasesRecruitingNo Results AvailableMetastases, Neoplasmhttps://ClinicalTrials.gov/show/NCT02265549
2284922849A Study of LY3022855 In Participants With Breast or Prostate CancerRecruitingNo Results AvailableNeoplasms|Neoplasm MetastasisDrug: LY3022855https://ClinicalTrials.gov/show/NCT02265536
2285022850Exercise and Cycle Ergometry Post TKA - A Randomized Controlled TrialNot yet recruitingNo Results AvailableOsteoarthritis|Deep Venous ThrombosisOther: Cycle ergometerhttps://ClinicalTrials.gov/show/NCT02265523
2285122851An Open-Label Study of a Novel JAK-inhibitor, INCB052793, Given to Patients With Advanced MalignanciesRecruitingNo Results AvailableAdvanced MalignanciesDrug: INCB052793|Drug: gemcitabine|Drug: nab-paclitaxel|Drug: dexamethasone|Drug: Carfilzomib|Drug: bortezomib|Drug: lenalidomide|Drug: azacitidine|Drug: INCB052793https://ClinicalTrials.gov/show/NCT02265510
2285222852Brazilian Network for Lymphoma RegistryRecruitingNo Results AvailableLymphomaOther: Observational, non-interventionhttps://ClinicalTrials.gov/show/NCT02265497
2285322853To Study the Efficacy of Bromocriptine in Patients With Hepatic/Cirrhosis Related ParkinsonismCompletedNo Results AvailableHepatic/Cirrhosis Related Parkinsonism.Drug: Lactulose+Rifaximin +Bromocriptinehttps://ClinicalTrials.gov/show/NCT02265484
2285422854Knowledge and Perception of Resistance to Antimicrobials Among Healthcare Workers in FranceRecruitingNo Results AvailableKnowledge, Perception and Behaviour of Resistance to Antimicrobial Among HCWhttps://ClinicalTrials.gov/show/NCT02265471
2285522855Musical Intervention in Non-invasive VentilationRecruitingNo Results AvailableRespiratory FailureBehavioral: Musical intervention and sensory isolationhttps://ClinicalTrials.gov/show/NCT02265458
2285622856Deescalating Carbapenems in Hospital SettingNot yet recruitingNo Results AvailableUrinary Infection|Digestive Infection|Biliary Infection|Expanded-spectrum Beta-lactamase Producing Enterobacteriaceae (ESBL-PE)Drug: Deescalation therapy|Drug: Maintaining carbapenem therapyhttps://ClinicalTrials.gov/show/NCT02265445
2285722857Using Mobile Technology to Promote Physical ActivityNot yet recruitingNo Results AvailablePhysical ActivityBehavioral: General physical activity educational materials|Device: Wearable activity tracking devices (fitbit)|Other: online map|Other: Personalized text messageshttps://ClinicalTrials.gov/show/NCT02265432
2285822858Use of Extracorporeal Treatment With the Cytosorb-Adsorber for the Reduction of SIRS in Heart Surgery PatientsRecruitingNo Results AvailableMultiple Organ FailureDevice: Extracorporeal treatment with the Cytosorb adsorberhttps://ClinicalTrials.gov/show/NCT02265419
2285922859PROPHY-VAP: Prevention of Early Ventilation Acquired Pneumonia (VAP) in Brain Injured Patients by a Single Dose of CeftriaxoneNot yet recruitingNo Results AvailablePreventing Early VAP in Brain Injured Patients.Drug: Anti-Infective Agents|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02265406
2286022860A 1-Year Safety Study of OTO-104 in Subjects With Unilateral Meniere's Disease Located in United KingdomActive, not recruitingNo Results AvailableMeniere's DiseaseDrug: OTO-104|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02265393

* Görseller ve İçerik tekif hakkına sahip olabilir